A Passion for Science and a Commitment to Dermatology

Dermavant Sciences is a clinical-stage biopharmaceutical company whose goal is to develop and commercialize innovative therapies for inflammatory skin diseases and medical dermatologic conditions. Our current pipeline consists of five product candidates intended to improve patients’ lives by targeting five different conditions with significant unmet medical needs. The patient is at the heart of everything we do.

Learn More

Latest News

October 11, 2018

Dermavant Sciences to Present Tapinarof Phase 2B D ...

Read More

September 4, 2018

Dermavant Announces Changes to Leadership and Boar ...

Read More

August 21, 2018

Dermavant Sciences Announces Closing of Transactio ...

Read More